Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Pharmacology Research & Perspectives|June 13, 2017
Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonistsSrinivasan Chandrasekhar, Xiao-Peng Yu, Anita K Harvey, et al.
British Journal of Haematology|October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) projectCharles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
The Journal of Bone and Joint Surgery. American Volume|February 22, 2013
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectBeatrice J Edwards, Andrew D Bunta, Joseph Lane, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivativesMatthew J Fisher, Ryan T Backer, Iván Collado, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2012
3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activityMatthew J Fisher, Ryan T Backer, Vanessa N Barth, et al.
Journal of Oncology Practice|December 4, 2014
Economics of Malignant Gliomas: A Critical ReviewJeffrey J Raizer, Karen A Fitzner, Daniel I Jacobs, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
Enabling reproducible type 1 diabetes polygenic risk scoring for clinical and translational applicationsMaizy S Brasher, Matthew J Fisher, Carolina Sanchez Wild, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2012
Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brainPaolo Zanotti-Fregonara, Vanessa N Barth, Jeih-San Liow, et al.
Kidney International. Supplement|January 31, 2009
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)Anaadriana Zakarija, Hau C Kwaan, Joel L Moake, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2016
Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitorsSteven L Kuklish, Stephen Antonysamy, Shobha N Bhattachar, et al.
Pageof 4